New therapeutic target discovered for a number of aggressive cancers
A protein in tumor cells could be targeted to treat some types of aggressive cancer including brain, blood, skin, and kidney, new research has shown.
Aug 4, 2021
0
177
A protein in tumor cells could be targeted to treat some types of aggressive cancer including brain, blood, skin, and kidney, new research has shown.
Aug 4, 2021
0
177
In April 2019, vascular surgeons in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo organized the first-ever Women's Vascular Summit, with attendees from around the country.
Jul 23, 2021
0
5
High-risk neuroblastoma is an aggressive childhood cancer with poor treatment outcomes. Despite intensive chemotherapy and radiotherapy, less than 50 percent of these children survive for five years. While the genetics of ...
Jul 7, 2021
0
2
In a bid to find or refine laboratory research models for cancer that better compare with what happens in living people, Johns Hopkins Medicine scientists report they have developed a new computer-based technique showing ...
Jun 17, 2021
0
16
According to the National Cancer Institute, colorectal cancer is the fourth most common cancer diagnosed in the United States, predicted to strike nearly 150,000 people in 2021. The agency also estimates the disease will ...
Jun 10, 2021
0
6
In a collaborative report published today in Cell, scientists from Sydney and New York describe the critical worldwide need to improve the diversity of cells used in medical research. Currently, 95% of all human cell lines ...
May 13, 2021
0
3
The resilience of cancer cells and their ability to survive in extreme conditions is a large part of what makes cancer so difficult to treat.
Apr 30, 2021
0
73
Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer ...
Apr 26, 2021
1
122
Many cancers hijack a metabolic mechanism known as the mTOR pathway to fuel growth and proliferation, and inhibiting that pathway could slow tumor growth, according to a Northwestern Medicine study published in Molecular ...
Apr 8, 2021
0
57
James McKerrow, MD, Ph.D., dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has long studied neglected tropical diseases—chronic and disabling parasitic infections ...
Apr 2, 2021
0
79